Guinea vs Niger: Previously treated cases tested for RR-/MDR-TB
Guinea
29.0%
in 2024
Niger
33.0%
in 2024
Guinea rank
161st
Niger rank
158th
Previously treated cases tested for RR-/MDR-TB over time
- Guinea
- Niger
How they compare
Niger currently reports 33.0% against 29.0% in Guinea, a difference of 4.0%.
That makes Niger's figure about 1.1 times Guinea's.
The two have swapped places 11 times across 15 shared years of data; in 2009 it was Guinea ahead.
Guinea ranks 161st and Niger ranks 158th of 180 countries.
Across the 3 decades both report, Guinea averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Guinea | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.0% | 4.8% | 6.2% | Guinea |
| 2010s | 45.9% | 48.4% | 2.5% | Niger |
| 2020s | 70.8% | 76.6% | 5.8% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guinea or Niger?
- Niger, at 33.0% against 29.0% in Guinea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guinea and Niger?
- 4.0%, with Niger ahead.
- How many years of comparable data are there for Guinea and Niger?
- 15 years are reported by both, from 2009 to 2024.
- How do Guinea and Niger rank globally for previously treated cases tested for rr-/mdr-tb?
- Guinea ranks 161st and Niger ranks 158th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.